Physician profile
Julia Isom
NPI 1093163339
$5,172.16
in general payments reported to CMS, 2019-2025
43 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $1,865 · 2021: $1,037 · 2022: $304 · 2023: $690 · 2024: $741 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,768.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $546.09 | 2019-2024 | Fasenra, Airsupra |
| Novo Nordisk INC | $490.32 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $350.96 | 2021-2025 | |
| Amarin Pharma, INC. | $287.64 | 2019-2021 | |
| Lilly USA, LLC | $287.25 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $266.91 | 2020-2025 | Shingrix, Arexvy, Boostrix |
| Amgen INC. | $259.53 | 2019-2021 | |
| Pfizer INC. | $236.90 | 2020-2025 | |
| Exact Sciences Corporation | $234.57 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.04 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $186.84 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $183.08 | 2019-2022 | |
| Abbott Laboratories | $130.40 | 2023-2025 | Freestyle Libre, Freestyle Libre 3, Eterna |
| Takeda Pharmaceuticals U.S.A., INC. | $126.06 | 2020-2024 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.90 | 2020-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Isom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.